[1]
2014. Interleukin-2 in Renal Cell Carcinoma: A Has-Been or a Still-Viable Option?. Journal of Kidney Cancer. 1, 7 (Nov. 2014), 74–83. DOI:https://doi.org/10.15586/jkcvhl.2014.18.